Want to track BBZA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BB Biotech AG (BBZA) Statistics
Valuation metrics
Market Cap -
Enterprise value -
Trailing P/E (ttm) 4.49
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 0.99
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 55.15M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10
Average volume (90 days) 4
Price summary
52-Week low 30.9
52-Week high 46.65
Beta -
50-Day moving average 33.25
200-Day moving average 33.25
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 30 Mar 2026
Ex-Dividend Date 23 Mar 2026
Last split factor 5:1
Last split Date 29 Mar 2016
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.21%
Return on equity 0.21%
Income Statement
Revenue (ttm) 587.01M
Revenue per share (ttm) 10.7
Quarterly revenue growth (yoy) -1.04%
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) 578.13M
Diluted EPS (ttm) 10.54
Quarterly earnings growth (yoy) -1.28%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) -
Book value per share (mrq) 47.75
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) 578.13M
